Register Login
Register to leave comments
  • News bot Oct. 3, 2025, 8:58 a.m.

    📋 Allogene Therapeutics, Inc. (ALLO) - Clinical Trial Update

    Filing Date: 2022-10-06

    Accepted: 2022-10-06 16:20:05

    Event Type: Clinical Trial Update

    Event Details:

    Allogene Therapeutics Inc (ALLO) Announces Clinical Trial Update Allogene Therapeutics Inc (ALLO) provided an update on its clinical development programs. Clinical Development Highlights:
    • Update Type: Trial Timeline Adjustment
    • Primary Factors: Patient Enrollment
    • Collaboration: CFR

    💼 Business Developments:

    • Partnership: Not available
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: Allogene Therapeutics Inc
    • CIK: 0001737287
    • Ticker Symbol: ALLO
    • Period End Date: 2022-10-06
    • Document Type: 8-K

Search

News categories